Capital Adept
  • Politics
  • Investing
  • Stocks
  • Business
  • Politics
  • Investing
  • Stocks
  • Business

Capital Adept

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Presentation to Food and Ingredients China 2025 Conference

March 19, 2025

Jeffrey Christian: Gold, Silver, PGMs — Short-term Prices...

June 21, 2025

Empire Metals: Advancing a Game-changing, Globally Significant Titanium...

May 1, 2025

Settlement of Tranche 1 Share Placement

June 26, 2025

New RAD202 data confirms positive tumor uptake

March 17, 2025

Completion of Airborne Survey Across NT Uranium Projects

May 27, 2025

Tech 5: CoreWeave and Applied Digital Strike Deal,...

June 10, 2025

Gold Price Hits New Record, Breaking US$3,000 for...

March 15, 2025

Trump Admin Strips “Safety” from AI Oversight Institute...

June 6, 2025

Tech 5: OpenAI Restructures, Apple Pursues AI Search,...

May 11, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Copper Price Update: Q1 2025 in Review

      April 14, 2025
    • 2

      The Best Five Sectors, #10

      March 14, 2025
    • 3

      DP Trading Room: Market Sell-Off

      March 14, 2025
    • 4

      5 Strong Stocks Defying the Bearish Market!

      March 14, 2025
    • 5

      Sector Rotation Warning: More Downside Ahead for US Markets?

      March 14, 2025
    • 6

      Transform Your Investing Strategy: Uncover the 3 Game-Changing Rules

      March 14, 2025
    • 7

      Did Friday’s Reversal Mark A Major Bottom?

      March 14, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 capitaladept.com | All Rights Reserved